Plant ID: NPO13010
Plant Latin Name: Allium stipitatum
Taxonomy Genus: Allium
Taxonomy Family: Amaryllidaceae
NCBI TaxonomyDB:
70767
Plant-of-the-World-Online:
528920-1
Unknown.
Turkey; Afghanistan; Iran; Turkmenistan; Pakistan; Kazakhstan; Uzbekistan; Iraq; Tajikistan
GPBAR1; | |
PTPN1; PTPN2; ACP1; PTPRF; CDC25B; | |
RECQL; HSD11B1; AKR1B10; IDO1; USP2; AOX1; GAPDH; | |
PRKCA; | |
CA1; CA12; CA5B; CA5A; CA6; | |
RORC; | |
NR1H4; | |
MAOB; | |
MMP12; METAP2; MMP2; | |
HTT; LMNA; MAPT; | |
L3MBTL1; SMN1;SMN2; |
Protein Class | Gene ID | Protein Name | Uniprot ID | Target ChEMBL ID |
---|---|---|---|---|
Cytochrome P450 family 1 | CYP1A2 | Cytochrome P450 1A2 | P05177 | CHEMBL3356 |
Cytochrome P450 family 2 | CYP2C19 | Cytochrome P450 2C19 | P33261 | CHEMBL3622 |
Cytochrome P450 family 2 | CYP2C9 | Cytochrome P450 2C9 | P11712 | CHEMBL3397 |
Cytochrome P450 family 2 | CYP2D6 | Cytochrome P450 2D6 | P10635 | CHEMBL289 |
Enzyme_unclassified | RECQL | ATP-dependent DNA helicase Q1 | P46063 | CHEMBL1293236 |
Enzyme_unclassified | HSD11B1 | 11-beta-hydroxysteroid dehydrogenase 1 | P28845 | CHEMBL4235 |
Enzyme_unclassified | AKR1B10 | Aldo-keto reductase family 1 member B10 | O60218 | CHEMBL5983 |
Enzyme_unclassified | IDO1 | Indoleamine 2,3-dioxygenase | P14902 | CHEMBL4685 |
Enzyme_unclassified | USP2 | Ubiquitin carboxyl-terminal hydrolase 2 | O75604 | CHEMBL1293227 |
Enzyme_unclassified | AOX1 | Aldehyde oxidase | Q06278 | CHEMBL3257 |
Enzyme_unclassified | GAPDH | Glyceraldehyde-3-phosphate dehydrogenase liver | P04406 | CHEMBL2284 |
Lyase | CA1 | Carbonic anhydrase I | P00915 | CHEMBL261 |
Lyase | CA12 | Carbonic anhydrase XII | O43570 | CHEMBL3242 |
Lyase | CA5B | Carbonic anhydrase VB | Q9Y2D0 | CHEMBL3969 |
Lyase | CA5A | Carbonic anhydrase VA | P35218 | CHEMBL4789 |
Lyase | CA6 | Carbonic anhydrase VI | P23280 | CHEMBL3025 |
Metallo protease | MMP12 | Matrix metalloproteinase 12 | P39900 | CHEMBL4393 |
Metallo protease | METAP2 | Methionine aminopeptidase 2 | P50579 | CHEMBL3922 |
Metallo protease | MMP2 | Matrix metalloproteinase-2 | P08253 | CHEMBL333 |
Methyl-lysine/arginine binding protein | L3MBTL1 | Lethal(3)malignant brain tumor-like protein 1 | Q9Y468 | CHEMBL1287622 |
Methyl-lysine/arginine binding protein | SMN1;SMN2 | Survival motor neuron protein | Q16637 | CHEMBL1293232 |
Nuclear hormone receptor subfamily 1 group F | RORC | Nuclear receptor ROR-gamma | P51449 | CHEMBL1741186 |
Nuclear hormone receptor subfamily 1 group H | NR1H4 | Bile acid receptor FXR | Q96RI1 | CHEMBL2047 |
Oxidoreductase | MAOB | Monoamine oxidase B | P27338 | CHEMBL2039 |
Protein Kinase | PRKCA | Protein kinase C alpha | P17252 | CHEMBL299 |
Protein Phosphatase | PTPN1 | Protein-tyrosine phosphatase 1B | P18031 | CHEMBL335 |
Protein Phosphatase | PTPN2 | T-cell protein-tyrosine phosphatase | P17706 | CHEMBL3807 |
Protein Phosphatase | ACP1 | Low molecular weight phosphotyrosine protein phosphatase | P24666 | CHEMBL4903 |
Protein Phosphatase | PTPRF | Receptor-type tyrosine-protein phosphatase F (LAR) | P10586 | CHEMBL3521 |
Protein Phosphatase | CDC25B | Dual specificity phosphatase Cdc25B | P30305 | CHEMBL4804 |
Small molecule receptor (family A GPCR) | GPBAR1 | G-protein coupled bile acid receptor 1 | Q8TDU6 | CHEMBL5409 |
Unclassified | HTT | Huntingtin | P42858 | CHEMBL5514 |
Unclassified | LMNA | Prelamin-A/C | P02545 | CHEMBL1293235 |
Unclassified | MAPT | Microtubule-associated protein tau | P10636 | CHEMBL1293224 |
GO Type | GO Category | Enriched GO Terms | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|---|
MF | GO:0003824; catalytic activity | GO:0004089; carbonate dehydratase activity | 4.297E-11 | 4.678E-07 | CA1, CA12, CA5A, CA5B, CA6 |
BP | GO:0008152; metabolic process | GO:0016098; monoterpenoid metabolic process | 1.351E-10 | 9.806E-07 | CYP1A2, CYP2C19, CYP2C9, CYP2D6 |
BP | GO:0008152; metabolic process | GO:0006730; one-carbon metabolic process | 5.249E-09 | 2.858E-05 | CA1, CA12, CA5A, CA5B, CA6 |
MF | GO:0005488; binding | GO:0008270; zinc ion binding | 9.734E-09 | 4.239E-05 | CA1, CA12, CA5A, CA5B, CA6, L3MBTL1, MMP12, MMP2, NR1H4, PRKCA, PTPN1, RORC |
BP | GO:0051179; localization | GO:0015701; bicarbonate transport | 1.497E-08 | 5.431E-05 | CA1, CA12, CA5A, CA5B, CA6 |
BP | GO:0008152; metabolic process | GO:0008202; steroid metabolic process | 2.544E-07 | 5.541E-04 | AKR1B10, CYP1A2, CYP2C19, CYP2C9, CYP2D6, HSD11B1, NR1H4 |
BP | GO:0008152; metabolic process | GO:0097267; omega-hydroxylase P450 pathway | 6.483E-07 | 1.008E-03 | CYP1A2, CYP2C19, CYP2C9 |
BP | GO:0008152; metabolic process | GO:0035335; peptidyl-tyrosine dephosphorylation | 9.178E-07 | 1.249E-03 | ACP1, CDC25B, PTPN1, PTPN2, PTPRF |
BP | GO:0050896; response to stimulus | GO:0042738; exogenous drug catabolic process | 1.186E-06 | 1.359E-03 | CYP1A2, CYP2C19, CYP2C9 |
BP | GO:0008152; metabolic process | GO:0070989; oxidative demethylation | 1.186E-06 | 1.359E-03 | CYP1A2, CYP2C9, CYP2D6 |
MF | GO:0005488; binding | GO:0019825; oxygen binding | 1.276E-06 | 1.390E-03 | CYP1A2, CYP2C19, CYP2C9, CYP2D6 |
BP | GO:0008152; metabolic process | GO:0006805; xenobiotic metabolic process | 1.848E-06 | 1.701E-03 | CYP1A2, CYP2C19, CYP2C9, CYP2D6, RORC |
MF | GO:0005488; binding | GO:0020037; heme binding | 3.270E-06 | 2.543E-03 | CYP1A2, CYP2C19, CYP2C9, CYP2D6, IDO1 |
BP | GO:0008152; metabolic process | GO:0019373; epoxygenase P450 pathway | 7.088E-06 | 4.823E-03 | CYP1A2, CYP2C19, CYP2C9 |
BP | GO:0009987; cellular process | GO:0038183; bile acid signaling pathway | 9.558E-06 | 6.052E-03 | GPBAR1, NR1H4 |
MF | GO:0060089; molecular transducer activity | GO:0038181; bile acid receptor activity | 9.558E-06 | 6.052E-03 | GPBAR1, NR1H4 |
MF | GO:0005488; binding | GO:0005506; iron ion binding | 9.727E-06 | 6.052E-03 | AOX1, CYP1A2, CYP2C19, CYP2C9, CYP2D6 |
Pathway Category Top Level | Pathway Category Second Level | Pathway ID | Pathway Name | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|---|---|
09100 Metabolism | 09111 Xenobiotics biodegradation and metabolism | hsa00982 | Drug metabolism - cytochrome P450 | 2.025E-09 | 1.073E-07 | CYP2C9, MAOB, CYP2D6, CYP1A2, AOX1, CYP2C19 |
09100 Metabolism | 09102 Energy metabolism | hsa00910 | Nitrogen metabolism | 7.425E-11 | 7.870E-09 | CA12, CA1, CA5B, CA5A, CA6 |
09100 Metabolism | 09105 Amino acid metabolism | hsa00380 | Tryptophan metabolism | 6.866E-07 | 2.426E-05 | MAOB, CYP1A2, AOX1, IDO1 |
09150 Organismal Systems | 09156 Nervous system | hsa04726 | Serotonergic synapse | 1.429E-06 | 3.787E-05 | CYP2C9, MAOB, CYP2D6, PRKCA, CYP2C19 |
09100 Metabolism | 09111 Xenobiotics biodegradation and metabolism | hsa00980 | Metabolism of xenobiotics by cytochrome P450 | 7.850E-06 | 1.664E-04 | HSD11B1, CYP2C9, CYP2D6, CYP1A2 |
09160 Human Diseases | 09161 Cancers | hsa05204 | Chemical carcinogenesis | 1.247E-05 | 2.204E-04 | HSD11B1, CYP2C9, CYP1A2, CYP2C19 |
Unclassified | Unclassified | hsa01100 | Metabolic pathways | 2.123E-04 | 2.501E-03 | HSD11B1, CYP2C9, AKR1B10, MAOB, CYP1A2, AOX1, CYP2C19, GAPDH, IDO1 |
09100 Metabolism | 09103 Lipid metabolism | hsa00591 | Linoleic acid metabolism | 1.739E-05 | 2.633E-04 | CYP2C9, CYP1A2, CYP2C19 |
09100 Metabolism | 09108 Metabolism of cofactors and vitamins | hsa00830 | Retinol metabolism | 1.991E-04 | 2.501E-03 | CYP2C9, CYP1A2, AOX1 |
09140 Cellular Processes | 09144 Cellular community - eukaryotes | hsa04520 | Adherens junction | 2.923E-04 | 3.098E-03 | PTPN1, ACP1, PTPRF |
ICD10 Disease Category | Disease Name | ICD10 Code | Associated Disease Targets (Association Ref: TTD database) |
---|---|---|---|
G00-G99: Diseases of the nervous system G00-G99 | Alzheimer disease | G30 | MAOB; |
NA: NA | Motor symptoms | NA | MAOB; |
I00-I99: Diseases of the circulatory system | Moderate to severe hypertension | I10-I16 | MAOB; |
E00-E89: Endocrine, nutritional and metabolic diseases | Obesity | E66 | MAOB; |
G00-G99: Diseases of the nervous system G00-G99 | Parkinson's disease | G20 | MAOB; |
F01-F99: Mental, Behavioral and Neurodevelopmental disorders | Depression | F30-F39 | MAOB; |
F01-F99: Mental, Behavioral and Neurodevelopmental disorders | Cognitive disorders | F01-F07, F04, F05, R41.3 | MAOB; |
F01-F99: Mental, Behavioral and Neurodevelopmental disorders | Anxiety disorder | F32, F40-F42 | MAOB; |
G00-G99: Diseases of the nervous system G00-G99 | Central nervous system disease | G00-G99 | MAOB; |
F01-F99: Mental, Behavioral and Neurodevelopmental disorders | Dementia | F01-F07 | MAOB; |
G00-G99: Diseases of the nervous system G00-G99 | Neurodegenerative disease | G30-G32 | MAOB; |
F01-F99: Mental, Behavioral and Neurodevelopmental disorders | Major depressive episode without melancholia | F30-F39 | MAOB; |
F01-F99: Mental, Behavioral and Neurodevelopmental disorders | Idiopathic parkinson's disease | F02.3, G20 | MAOB; |
A00-B99: Certain infectious and parasitic diseases | Bacterial infections | A00-B99 | MAOB; |
F01-F99: Mental, Behavioral and Neurodevelopmental disorders | Major depressive disorder | F32, F33, M32 | MAOB; |